Literature DB >> 7724399

Implantable defibrillation and thromboembolic events.

G Benedini1, A Marchini, A Curnis, F Bianchetti, A Gardini, P Pinetti, E Zanelli.   

Abstract

In ICD patients thromboembolic events (TEEs) are described as possible complications at implant or during the follow-up. We report four cases of TEEs (two peripheral and two cerebral; 6.5% of patients) that occurred in our series during a mean follow-up of 19.4 months. The patients had chronic postinfarction LV aneurysm (3) and idiopathic dilated cardiomyopathy (1). None had previous embolisms nor evidence of left atrial or LV clots at standard preoperative transthoracic echocardiography. No paroxysms of atrial fibrillation were documented prior or after ICD implant. We discuss the possible causes of embolization and the suitability of anticoagulant therapy in ICD patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7724399     DOI: 10.1111/j.1540-8159.1995.tb02504.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  5 in total

1.  Effect of defibrillation threshold testing-induced ventricular fibrillation on renal function.

Authors:  John H Shin; Chotikorn Khunnawat; Jose Baez-Escudero; Bradley P Knight; John F Beshai
Journal:  J Interv Card Electrophysiol       Date:  2013-10-11       Impact factor: 1.900

2.  [Is the determination of the defibrillation threshold in patients with an implantable cardioverter-defibrillator still required?].

Authors:  M Licka; L Jahn; K Kelemen; F Voss; K Trappe; R Becker; O Bikou; M Hauck; M Koch; H A Katus; A Bauer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-11-13

3.  A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study.

Authors:  Maurizio Gasparini; Carlo Menozzi; Alessandro Proclemer; Maurizio Landolina; Severio Iacopino; Angelo Carboni; Ernesto Lombardo; François Regoli; Mauro Biffi; Valeria Burrone; Alessandra Denaro; Giuseppe Boriani
Journal:  Eur Heart J       Date:  2009-06-29       Impact factor: 29.983

4.  Implantable cardioverter defibrillator shock embolizes an atrial septal occluder device in Brugada syndrome.

Authors:  Kothandam Sivakumar; Sreeja Pavithran; Amal Louis; Radhakrishnan Satish
Journal:  Pediatr Cardiol       Date:  2012-07-15       Impact factor: 1.655

Review 5.  Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women?

Authors:  Annabelle Santos Volgman; C Noel Bairey Merz; Neelum T Aggarwal; Vera Bittner; T Jared Bunch; Philip B Gorelick; Pauline Maki; Hena N Patel; Athena Poppas; Jeremy Ruskin; Andrea M Russo; Shari R Waldstein; Nanette K Wenger; Kristine Yaffe; Carl J Pepine
Journal:  J Am Heart Assoc       Date:  2019-09-24       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.